AMG 334

DRUG2 trials

Sponsors

Danish Headache Center, Messoud Ashina

Conditions

Mild Traumatic Brain InjuryPost-Concussion SyndromePost-Traumatic HeadacheRosacea

Phase 2

Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache

CompletedNCT03974360

Danish Headache CenterMild Traumatic Brain Injury, Post-Concussion Syndrome, Post-Traumatic Headache

Start: 2019-04-05End: 2019-12-31Updated: 2020-02-10

Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea

Messoud AshinaRosacea

Start: 2020-06-09End: 2021-08-31Target: 30Updated: 2020-06-11

Related Papers

Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea: A Nonrandomized Controlled Trial.

2024-06-0113 citations

Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study

The Journal of Headache and Pain2020-06-0373 citations